Zelira Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 21 shareholders own 49.75% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10%	Malik Majeed	1,134,644	AU$805.6k	0%	no data
4.02%	Quincy Street Capital Llc	456,622	AU$324.2k	0%	no data
3.78%	Osagie Imasogie	428,883	AU$304.5k	0%	no data
3.46%	Zoltan Kerekes	393,168	AU$279.1k	0%	no data
3.46%	Sharri Rochlin	393,168	AU$279.1k	0%	no data
3.38%	Jason Peterson	383,725	AU$272.4k	0%	no data
3.37%	Lisa Gray	381,988	AU$271.2k	0%	no data
2.93%	Mera I LLC	332,479	AU$236.1k	0%	no data
2.71%	Torsten Geers	307,454	AU$218.3k	0%	no data
2.67%	Steve Shapiro	302,571	AU$214.8k	0%	no data
2.22%	Mara Gordon	252,242	AU$179.1k	0%	no data
1.29%	Chanda Macias	146,479	AU$104.0k	0%	no data
1.18%	Mera II LLC	133,372	AU$94.7k	0%	no data
1.16%	Oludare Odumosu	131,766	AU$93.6k	0%	no data
1.04%	Muller Ct Pty Ltd	118,107	AU$83.9k	0%	no data
0.76%	Geers Egag LLC	85,715	AU$60.9k	0%	no data
0.67%	Saul Shorr	75,643	AU$53.7k	0%	no data
0.67%	Margaret Shorr	75,642	AU$53.7k	0%	no data
0.46%	Daniel Hexter	51,695	AU$36.7k	0%	no data
0.46%	Shannon Hexter	51,694	AU$36.7k	0%	no data
0.069%	Timothy Slate	7,881	AU$5.6k	0%	no data